Treace Medical Concepts Inc (TMCI)
4.78
+0.12
(+2.58%)
USD |
NASDAQ |
Nov 01, 16:00
4.775
0.00 (0.00%)
After-Hours: 20:00
Treace Medical Concepts Enterprise Value: 255.38M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 255.38M |
| October 31, 2024 | 247.92M |
| October 30, 2024 | 256.00M |
| October 29, 2024 | 257.87M |
| October 28, 2024 | 259.11M |
| October 25, 2024 | 249.78M |
| October 24, 2024 | 264.71M |
| October 23, 2024 | 274.04M |
| October 22, 2024 | 288.34M |
| October 21, 2024 | 291.45M |
| October 18, 2024 | 290.21M |
| October 17, 2024 | 287.10M |
| October 16, 2024 | 292.07M |
| October 15, 2024 | 288.96M |
| October 14, 2024 | 281.50M |
| October 11, 2024 | 285.23M |
| October 10, 2024 | 274.04M |
| October 09, 2024 | 283.37M |
| October 08, 2024 | 280.26M |
| October 07, 2024 | 283.99M |
| October 04, 2024 | 290.21M |
| October 03, 2024 | 286.48M |
| October 02, 2024 | 297.05M |
| October 01, 2024 | 294.56M |
| September 30, 2024 | 318.82M |
| Date | Value |
|---|---|
| September 27, 2024 | 316.95M |
| September 26, 2024 | 318.82M |
| September 25, 2024 | 290.21M |
| September 24, 2024 | 295.80M |
| September 23, 2024 | 287.10M |
| September 20, 2024 | 296.43M |
| September 19, 2024 | 306.38M |
| September 18, 2024 | 298.91M |
| September 17, 2024 | 282.12M |
| September 16, 2024 | 269.68M |
| September 13, 2024 | 276.53M |
| September 12, 2024 | 272.79M |
| September 11, 2024 | 279.64M |
| September 10, 2024 | 282.74M |
| September 09, 2024 | 280.88M |
| September 06, 2024 | 289.59M |
| September 05, 2024 | 297.05M |
| September 04, 2024 | 312.60M |
| September 03, 2024 | 313.84M |
| August 30, 2024 | 341.83M |
| August 29, 2024 | 348.04M |
| August 28, 2024 | 348.04M |
| August 27, 2024 | 339.96M |
| August 26, 2024 | 348.67M |
| August 23, 2024 | 357.37M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
201.65M
Minimum
May 08 2024
1.926B
Maximum
Jun 11 2021
975.00M
Average
989.23M
Median
Enterprise Value Benchmarks
| Stryker Corp | 150.76B |
| Perspective Therapeutics Inc | 524.04M |
| Retractable Technologies Inc | -19.02M |
| Xtant Medical Holdings Inc | 102.06M |
| Catheter Precision Inc | 2.058M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.21M |
| Revenue (Quarterly) | 44.46M |
| Total Expenses (Quarterly) | 65.84M |
| EPS Diluted (Quarterly) | -0.34 |
| Gross Profit Margin (Quarterly) | 80.25% |
| Profit Margin (Quarterly) | -47.70% |
| Earnings Yield | -21.39% |
| Normalized Earnings Yield | -21.39 |